Welcome to CARGlobalTrials
Chimeric Antigen Receptors (CARs, visualized above) are engineered therapies that enable a patient's immune system to target specific cells - such as cancer. This site was created to aid researchers, clinicians, and patients to better understand the current clinical landscape of CARs, plan new therapies, and find trials of interest.

CARGlobalTrials is developed by Matthew MacKay in the Mason Lab at Weill Cornell Medicine details are also published in Nature Biotechnology.

We can help! Click on a link below to contact us.